Skip to main content
All lobbying filings

LOBBYING FOR IMPROVEMENTS

Lobbying for LIFEWAY FOODS, INC · Manufacturing and distributing kefir, a cultured dairy product

 Filing · LD-1 registration Registration
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Jan 5, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Illinois

Official filing document

 Lobbying activity 7

Ensuring kefir is recognized as a valuable product by the FDA, included in Medicaid Food as Medicine programs, covered by health insurance and Medicare for populations that need probiotics, provided fair access to the Canadian consumer market and acknowledged as an important American export by agencies that support manufacturers.

Ensuring kefir is recognized as a valuable product by the FDA, included in Medicaid Food as Medicine programs, covered by health insurance and Medicare for populations that need probiotics, provided fair access to the Canadian consumer market and acknowledged as an important American export by agencies that support manufacturers.

Ensuring kefir is recognized as a valuable product by the FDA, included in Medicaid Food as Medicine programs, covered by health insurance and Medicare for populations that need probiotics, provided fair access to the Canadian consumer market and acknowledged as an important American export by agencies that support manufacturers.

Ensuring kefir is recognized as a valuable product by the FDA, included in Medicaid Food as Medicine programs, covered by health insurance and Medicare for populations that need probiotics, provided fair access to the Canadian consumer market and acknowledged as an important American export by agencies that support manufacturers.

Ensuring kefir is recognized as a valuable product by the FDA, included in Medicaid Food as Medicine programs, covered by health insurance and Medicare for populations that need probiotics, provided fair access to the Canadian consumer market and acknowledged as an important American export by agencies that support manufacturers.

Ensuring kefir is recognized as a valuable product by the FDA, included in Medicaid Food as Medicine programs, covered by health insurance and Medicare for populations that need probiotics, provided fair access to the Canadian consumer market and acknowledged as an important American export by agencies that support manufacturers.

Ensuring kefir is recognized as a valuable product by the FDA, included in Medicaid Food as Medicine programs, covered by health insurance and Medicare for populations that need probiotics, provided fair access to the Canadian consumer market and acknowledged as an important American export by agencies that support manufacturers.

 Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

  • DANONE
    France · Paris · owns 20% of the client · contributed $0

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem